Zeinab Yahia Zaki
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| JAM3 as a Prognostic Biomarker in Muscle-Invasive Urothelial Carcinoma: Correlation With Therapeutic Response, and Survival Outcomes (NCT06901934) | Zeinab Yahia Zaki | 2025-10-01 |
Track Zeinab Yahia Zaki automatically
Every clearance here is in the API, with alerts when new ones post.